Antimicrobial Therapy

Introduction

  • Host: Doctor Halterman, a pharmacist with experience in both inpatient and outpatient settings

  • Focus of the lecture: Antimicrobial therapy

Course Structure

  • Interaction with the Utah cohort and Colorado students

  • Progression into the pharmacology department in the second year:
      - Learning basic science and pathophysiology
      - More in-depth focus on pharmacology and treatment options

  • Importance of familiarity with pharmacology department in the second year

Lecture Overview

  • Introduction to antimicrobial therapy

  • Discussion on different classes of antimicrobials:
      - Antivirals
      - Antifungals
      - Antibacterials

  • Goal: Familiarize with common drugs and drug classes

  • Future courses will cover disease state-specific treatments, e.g., tuberculosis antibiotics in respiratory studies

  • Importance of connecting drug knowledge with learning about microbes

Learning Objectives

  • Compare and contrast types and goals of therapy for different pathogens

  • Recognize major classes of infective drugs and specific major drugs within each class

  • Define and discuss key terms:
      - Antibiotic resistance
      - Bactericidal vs. bacteriostatic
      - Spectrum of activity
      - Minimum inhibitory concentration (MIC)
      - Resistant vs. sensitive

  • Mechanisms of action, indications, and adverse effects of major drug classes

  • Importance of understanding adverse effects ranging from common to serious

  • Note contraindications or pharmacokinetic properties of the drugs

  • Application of lecture material in clinical case scenarios

UWorld and Study Resources

  • Importance of UWorld for second-year students
      - Initially difficult, but essential for clinical knowledge
      - Availability of relevant questions pertaining to the lecture’s material on Canvas

Matching Game Overview

  • Understanding appropriate use of antimicrobial therapy:
      - Antibiotics for bacterial infections
      - Antifungals for fungal infections
      - Antivirals for viral infections
      - Awareness of secondary bacterial infections stemming from viral issues

Bacterial Infections Identification

  • Key identification methods: Gram stain
      - Differentiates gram-positive and gram-negative bacteria based on cell wall structure

  • Importance of biochemical tests (e.g., coagulase, catalase) and PCR for identifying organisms

Gram Staining and Bacterial Structure

  • Distinction:
      - Gram-positive: Thick peptidoglycan layer, stains dark purple
      - Gram-negative: Thinner peptidoglycan layer, surrounded by an outer membrane, stains light pink

  • Importance of beta-lactam antibiotics and associated enzymes in relation to bacterial structure

  • Significance of understanding cell wall structures for effective antibiotic selection

Cell Wall Structure and Targeting

  • Components of the peptidoglycan layer:
      - Glycans (sugars) connected horizontally
      - Peptides connected vertically
      - Understanding drug targets ('transglycosylase' and 'transpeptidase')

  • Implications of the structural differences in antibiotic efficacy

Overview of Major Antibiotic Classes

Beta-Lactams

  • Key subcategories:
      - Penicillins
      - Cephalosporins
      - Carbapenems
      - Monobactam (Aztreonam)

  • Beta-lactamase inhibitors:
      - Functionality in preserving beta-lactam efficacy

Important Drugs

  • Penicillins:
      - Amoxicillin, Nafcillin, Ampicillin

  • Cephalosporins:
      - Generations
        - First Generation: Cefazolin, Cephalexin
        - Second Generation: Cefuroxime, Cefoxitin
        - Third Generation: Ceftriaxone, Cefpodoxime, Ceftazidime
        - Fourth Generation: Cefepime
        - Fifth Generation: Ceftaroline

  • Carbapenems: Meropenem identified as main drug

  • Monobactam: Aztreonam as singular representative

  • Beta-lactamase Inhibitors:
      - Amoxicillin + Clavulanic Acid
      - Piperacillin + Tazobactam
      - Ampicillin + Sulbactam

Other Key Classes

  • Glycopeptides: Vancomycin

  • Quinolones: Ciprofloxacin, Levofloxacin

  • Aminoglycosides: Gentamicin

  • Tetracyclines: Doxycycline

  • Macrolides: Azithromycin

  • Miscellaneous: Nitrofurantoin, Metronidazole, Sulfamethoxazole/Trimethoprim

Mechanism of Action Classifications

  • Classification based on site of action or mechanism

  • Main classes:
      - Inhibitors of cell wall synthesis
      - Inhibitors of cell membrane function
      - Inhibitors of nucleic acid function/synthesis
      - Inhibitors of protein synthesis
      - Metabolism inhibitors

  • Focus on the impact of cell wall synthetic inhibitors on microbial life

Factors Influencing Antibiotic Selection

  • Identifying the site of infection to target specific pathogens

  • Type of antimicrobial required: empiric, definitive, or prophylactic

  • Understanding the drug's spectrum of activity

  • Considering patient-specific factors (renal function, drug allergies, etc.)

  • Importance of dosing in achieving efficacy and minimizing resistance

  • Combination therapy approaches for enhanced effectiveness

Antimicrobial Treatment Strategies

Prophylactic Therapy

  • Given to prevent an infection (e.g., surgical prophylaxis using Cefazolin)

Empiric Therapy

  • Initiated when infection is suspected, but causative agent is unknown; broad spectrum used

Definitive Therapy

  • Initiated once causative pathogen is identified, allowing for targeted treatment

Continuum of Antimicrobial Use

  • Process from suspected infection to culture collection to definitive therapy

  • Importance of timely re-evaluation of therapy based on treatment response

Spectrum of Activity Analogy

  • Discussion through a packing analogy:
      - Narrow spectrum packaging (specific) vs. broad spectrum (comprehensive)
      - Implications of antibiotic coverage based on likely pathogens

Susceptibility Testing

  • Understanding MIC as the lowest concentration inhibiting bacterial growth

  • CLSI guidelines for breakpoint determination to classify susceptibility

Patient Case Study: UTI

Patient Profile

  • Patient: 44-year-old female with urinary symptoms

  • Urinalysis shows evidence of UTI

Culture and Susceptibility Report

  • E. Coli identified as offending pathogen

  • Testing for several antibiotics with interpretation of results

  • Importance of not solely relying on the lowest MIC for drug selection; clinical knowledge and guidelines help guide best choices

  • Recommended first-line therapy: Nitrofurantoin based on clinical guidelines

Conclusion

  • Importance of understanding the full scope of antimicrobial therapy, from identification to specific drug selection based on patient needs and microbiological data

  • The need to balance theoretical knowledge with practical clinical applications to enhance patient care and outcomes.